Eris Lifesciences has announced that Krishnakumar Vaidyanathan has resigned from his position as Executive Director and Chief Operating Officer to pursue professional opportunities outside the organization.

The leadership transition will take effect at the close of business hours on September 30, 2026. This exit of a key member of the core operational team impacts the company's senior management structure, making the upcoming management succession strategy crucial for stakeholders monitoring operational stability and execution capabilities going forward.